Advos

Salon and Spa Galleria is expanding its salon suite offerings in Haltom City, Texas, providing independent beauty professionals with flexible, move-in-ready workspaces along a high-traffic corridor.

Land Legends is expanding its focus on subdivision and development to unlock the potential of vacant land, moving beyond simple acquisition and resale.

Bubba Goodcrumb's nationwide launch of its Bubba's Baby sourdough boule plush and holiday starter bundles signals a growing market for baking-themed collectibles and living sourdough cultures.

Dietmar Heinisser has resigned from ANDRITZ AG's Executive Board for personal reasons, prompting CEO Joachim Schonbeck to take over his duties, a change that could affect the company's Environment & Energy and manufacturing strategies.

AT&S and Marvell Technology have expanded their collaboration to increase advanced IC substrate capacity for next-generation AI and cloud infrastructure, supporting the growing demand for AI deployments.

R. STAHL AG has appointed Elke Eckstein to its Supervisory Board, effective immediately, ensuring the board remains fully operational until the next Annual General Meeting.

HomeToGo SE's public Class A and Class B warrants have expired without value, eliminating potential dilution and simplifying the company's capital structure.

EPH Group AG plans a five-star resort in Burgenland, Austria, with around 300 beds, aiming to boost year-round tourism and regional value creation.

Greenland Mines has applied for a new exploration license covering approximately 262 square kilometres east of its Sarfartoq project, potentially expanding its controlled rare earth district from 192 to 454 square kilometres.

VERAXA Biotech (NASDAQ: VRXA) is advancing its oncology pipeline centered on the BiTAC platform, following its NASDAQ listing and key executive appointments, with early preclinical evidence for two therapeutic approaches.

Greenland Mines Ltd (NASDAQ: GRML) endorsed a new trilateral security agreement signed at the United Nations General Assembly, positioning its Sarfartoq and Skaergaard projects as key suppliers of critical minerals for the United States and Western allies.

Morph Brand's new Vera line uses an engraved pure-titanium surface to achieve non-stick cooking without PFAS, PTFE, or PFOA, addressing growing regulatory and consumer concerns about chemical coatings.

MAX Power Mining's placement in an AINewsWire editorial highlights how AI's massive electricity demand could drive interest in natural hydrogen as a primary energy source.

Nightfood Holdings' subsidiary TechForce Robotics was highlighted in an AINewsWire editorial examining the wafer inspection market's growth, driven by demand for advanced semiconductor packaging for AI infrastructure.

Quantum BioPharma is developing Lucid-MS, a drug candidate that targets an enzyme to inhibit demyelination, offering a potential new path for multiple sclerosis treatments.

Knightscope reports approximately $27 million in estimated renewals, bookings, and client awards, signaling growing demand for its Autonomous Security Force.

Greenland Mines is seeking a new license that could double its exploration footprint in Greenland, as Western nations push to diversify critical mineral supply chains.

Uranium Energy Corp. will release its fiscal 2026 year-end financial and operating results before markets open on Sept. 29, 2026, followed by a conference call at 11 a.m. EDT, a key event for investors tracking the largest and fastest-growing uranium company in the United States.

Tovel AI's new Card recorder captures conversations and prepares CRM, calendar, and task records only after user approval, challenging the autonomous agent trend and aiming to solve long-standing CRM adoption problems.

Roth Capital Partners will host its 5th Annual Healthcare Opportunities Conference on Sept. 29, 2026, in New York City, bringing together executives from over 30 public healthcare companies and institutional investors to discuss key industry trends and challenges.

Tonix Pharmaceuticals' second major managed Medicare agreement for TONMYA expands coverage to 32 million Medicare lives and 166 million total covered lives, significantly improving access to the first new fibromyalgia treatment in over 15 years.